Refine
Has Fulltext
- yes (37)
Is part of the Bibliography
- yes (37)
Year of publication
Document Type
- Journal article (37)
Language
- English (37)
Keywords
- DNA methylation (9)
- epigenetics (3)
- Medizin (2)
- STR profile (2)
- bisulfite pyrosequencing (2)
- copy number variation (2)
- exome sequencing (2)
- extracellular matrix (2)
- fetal programming (2)
- fibrosis (2)
- genomic imprinting (2)
- gestational diabetes mellitus (2)
- hearing loss (2)
- hepatic stellate cell (2)
- liver (2)
- methylation (2)
- myofibroblast (2)
- sperm DNA methylation (2)
- (classical and atypical) Werner syndrome (1)
- 3D modeling (1)
- 5-methylcytosine (1)
- ADHD (1)
- ART outcome (1)
- Autism (1)
- Autism spectrum disorders (1)
- BRCA1 (1)
- CAGSSS (1)
- CDC14A (1)
- CLRN2 (1)
- Checkpoints (1)
- Copy number variation (1)
- Cortex (1)
- DFNB32 (1)
- DFNB68 (1)
- DNA Methylation (1)
- DNA damage (1)
- DNA double-strand break (1)
- DNA methylation dynamics (1)
- Damage (1)
- Down syndrome (1)
- Environment (1)
- Epigenetics (1)
- FISH (1)
- Familial Beckwith-Wiedemann syndrome (1)
- Fetal brain development (1)
- Frontal cortex (1)
- GTL2 (1)
- Gecko (1)
- Gene-expression (1)
- Genes (1)
- Genome (1)
- Genotype-phenotype association (1)
- Human prefrontal cortex (1)
- IARS2 (1)
- ICSI (1)
- IMSI (1)
- Instability (1)
- Malignant neoplasms (1)
- Methylome (1)
- Neanderthal (1)
- Pakistan (1)
- Parent-of-origin (1)
- Patterns (1)
- Repair (1)
- S1PR2 (1)
- SKY analysis (1)
- SLC2A3 (1)
- SNP array (1)
- SNP-microarray (1)
- Schizophrenia (1)
- Stability (1)
- Suicidal behavior (1)
- Susceptibility (1)
- Terminal 4q deletion syndrome (1)
- Th17 (1)
- Transcription (1)
- Transcription regulation (1)
- Tregs (1)
- Usher syndrome (1)
- Y chromosome degeneration (1)
- ZW sex chromosomes (1)
- adenoma (1)
- adipose (1)
- adipose tissue dysfunction (1)
- adrenal insufficiency (1)
- age-related differentially methylated regions (ageDMRs) (1)
- alu elements (1)
- antidepressants (1)
- anxiety disorders (1)
- autosomal recessive hearing loss (1)
- autosomal recessive non-synstromic hearing loss (1)
- banding analyses (1)
- blood (1)
- cancer treatment (1)
- cataracts (1)
- childhood cancer (1)
- combined retinal dystrophy (1)
- complex chromosome rearrangements (1)
- complex disorders (1)
- consanguinity (1)
- deafness (1)
- deep bisulfite sequencing (1)
- developmental origins hypothesis (1)
- duplication-deficiency (1)
- epigenetic heterogeneity (1)
- epimutation (1)
- fetal brain development (1)
- fetal cord blood (1)
- fetal overnutrition (1)
- fibroblasts (1)
- frameshift (1)
- frontal cortex (1)
- geckos (1)
- gene (1)
- gene expression (1)
- genetic diagnosis (1)
- genetic heterogeneity (1)
- genetics (1)
- genome-wide association study (GWAS) (1)
- genome-wide linkage analysis (1)
- genotyping arrays (1)
- growth hormone deficiency (1)
- haploinsufficiency (1)
- hearing impairment (1)
- hereditary hearing loss (1)
- heterochromatin (1)
- histological subtype (1)
- human evolution (1)
- hypoxia-inducible factor 3A (1)
- illumina (1)
- in vitro model (1)
- induced pluripotent stem cells (1)
- infinium HumanOmni1-Quad (1)
- inflammatory diseases (1)
- insulin treatment (1)
- karyotype evolution (1)
- mammalian male germline (1)
- meiosis (1)
- meiotic chromosomes (1)
- metabolic disease (1)
- methylation array (1)
- mitotic chromosomes (1)
- mixed hearing loss (1)
- mixed mutation mechanisms (1)
- monozygotic twins (1)
- next generation sequencing (1)
- next-generation sequencing (1)
- non-sense mediated mRNA decay (1)
- obesity (1)
- panic disorder (1)
- paternal age effect (1)
- phalloidin stain (1)
- polymerase chain reaction (1)
- premature aging (1)
- promoter methylation (1)
- protocadherin gamma cluster (1)
- reciprocal translocation (1)
- recombination (1)
- recurrence (1)
- regulatory T cells (1)
- rhodamine–phalloidin stain (1)
- secondary cancer (1)
- segmental progeria (1)
- sensorineural hearing loss (1)
- sensory neuropathy (1)
- sequence alignment (1)
- sex chromosomes (1)
- sex linked pigmentation pattern (1)
- sexual antagonistic genes (1)
- skeletal dysplasia (1)
- somatic mosaicism (1)
- species-specific epigenetic marks (1)
- spectral karyotyping (1)
- sperm (1)
- splicing (1)
- stress fibers (1)
- structural genome variations (1)
- submicroscopic chromosome rearrangement (1)
- suppression (1)
- synaptonemal complex (1)
- systemic sclerosis (1)
- telomere length (1)
- testosterone (1)
- tinnitus (1)
- transcription deficiency (1)
- treatment guidelines (1)
- triplosufficiency (1)
- trisomy 21 (1)
- twin study (1)
- type II esophageal achalasia (1)
- whole exome sequencing (1)
Institute
- Institut für Humangenetik (36)
- Theodor-Boveri-Institut für Biowissenschaften (11)
- Kinderklinik und Poliklinik (2)
- Klinik und Poliklinik für Hals-, Nasen- und Ohrenkrankheiten, plastische und ästhetische Operationen (2)
- Institut für Anatomie und Zellbiologie (1)
- Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie (1)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (1)
- Klinik und Poliklinik für Unfall-, Hand-, Plastische und Wiederherstellungschirurgie (Chirurgische Klinik II) (1)
- Lehrstuhl für Molekulare Psychiatrie (1)
- Medizinische Klinik und Poliklinik II (1)
Sonstige beteiligte Institutionen
Background
Terminal deletions of chromosome 4q are associated with a broad spectrum of phenotypes including cardiac, craniofacial, digital, and cognitive impairment. The rarity of this syndrome renders genotype-phenotype correlation difficult, which is further complicated by the widely different phenotypes observed in patients sharing similar deletion intervals.
Case presentation
Herein, we describe a boy with congenital hearing impairment and a variety of moderate syndromic features that prompted SNP array analysis disclosing a heterozygous 6.9 Mb deletion in the 4q35.1q35.2 region, which emerged de novo in the maternal germ line.
Conclusion
In addition to the index patient, we review 35 cases from the literature and DECIPHER database to attempt genotype-phenotype correlations for a syndrome with great phenotypic variability. We delineate intervals with recurrent phenotypic overlap, particularly for cleft palate, congenital heart defect, intellectual disability, and autism spectrum disorder. Broad phenotypic presentation of the terminal 4q deletion syndrome is consistent with incomplete penetrance of the individual symptoms.
The epidemic increase of type 2 diabetes and obesity in developed countries cannot be explained by overnutrition, physical inactivity and/or genetic factors alone. Epidemiologic evidence suggests that an adverse intrauterine environment, in particular a shortage or excess of nutrients is associated with increased risks for many complex diseases later in life. An impressive example for the ‘fetal origins of adult disease’ is gestational diabetes mellitus which usually presents in 1% to >10% of third trimester pregnancies. Intrauterine hyperglycemia is not only associated with increased perinatal morbidity and mortality, but also with increased lifelong risks of the exposed offspring for obesity, metabolic, cardiovascular and malignant diseases. Accumulating evidence suggests that fetal overnutrition (and similarly undernutrition) lead to persistent epigenetic changes in developmentally important genes, influencing neuroendocrine functions, energy homeostasis and metabolism. The concept of fetal programming has important implications for reproductive medicine. Because during early development the epigenome is much more vulnerable to environmental cues than later in life, avoiding adverse environmental factors in the periconceptional and intrauterine period may be much more important for the prevention of adult disease than any (i.e. dietetic) measures in infants and adults. A successful pregnancy should not primarily be defined by the outcome at birth but also by the health status in later life.
We describe monozygotic twins discordant for childhood leukemia and secondary thyroid carcinoma. We used bisulfite pyrosequencing to compare the constitutive promoter methylation of BRCA1 and several other tumor suppressor genes in primary fibroblasts. The affected twin displayed an increased BRCA1 methylation (12%), compared with her sister (3%). Subsequent bisulfite plasmid sequencing demonstrated that 13% (6 of 47) BRCA1 alleles were fully methylated in the affected twin, whereas her sister displayed only single CpG errors without functional implications. This between-twin methylation difference was also found in irradiated fibroblasts and untreated saliva cells. The BRCA1 epimutation may have originated by an early somatic event in the affected twin: approximately 25% of her body cells derived from different embryonic cell lineages carry one epigenetically inactivated BRCA1 allele. This epimutation was associated with reduced basal protein levels and a higher induction of BRCA1 after DNA damage. In addition, we performed a genome-wide microarray analysis of both sisters and found several copy number variations, i.e., heterozygous deletion and reduced expression of the RSPO3 gene in the affected twin. This monozygotic twin pair represents an impressive example of epigenetic somatic mosaicism, suggesting a role for constitutive epimutations, maybe along with de novo genetic alterations in recurrent tumor development.
Genetic defects in breast cancer (BC) susceptibility genes, most importantly BRCA1 and BRCA2, account for ∼40% of hereditary BC and ovarian cancer (OC). Little is known about the contribution of constitutive (soma-wide) epimutations to the remaining cases. We developed bisulfite pyrosequencing assays to screen >600 affected BRCA1/BRCA2 mutation-negative patients from the German Consortium for Hereditary Breast and Ovarian Cancer for constitutive hypermethylation of ATM, BRCA1, BRCA2, RAD51C, PTEN and TP53 in blood cells. In a second step, patients with ≥6% promoter methylation were analyzed by bisulfite plasmid sequencing to demonstrate the presence of hypermethylated alleles (epimutations), indicative of epigenetic gene silencing. Altogether we identified nine (1.4%) patients with constitutive BRCA1 and three (0.5%) with RAD51C hypermethylation. Epimutations were found in both sporadic cases, in particular in 2 (5.5%) of 37 patients with early-onset BC, and familial cases, in particular 4 (10%) of 39 patients with OC. Hypermethylation was always confined to one of the two parental alleles in a subset (12–40%) of the analyzed cells. Because epimutations occurred in cell types from different embryonal layers, they most likely originated in single cells during early somatic development. We propose that analogous to germline genetic mutations constitutive epimutations may serve as the first hit of tumor development. Because the role of constitutive epimutations in cancer development is likely to be largely underestimated, future strategies for effective testing of susceptibility to BC and OC should include an epimutation screen.
Background:
The etiology of secondary cancer in childhood cancer survivors is largely unclear. Exposure of normal somatic cells to radiation and/or chemotherapy can damage DNA and if not all DNA lesions are properly fixed, the mis-repair may lead to pathological consequences. It is plausible to assume that genetic differences, i.e. in the pathways responsible for cell cycle control and DNA repair, play a critical role in the development of secondary cancer.
Methodology/Findings:
To identify factors that may influence the susceptibility for second cancer formation, we recruited 20 individuals who survived a childhood malignancy and then developed a second cancer as well as 20 carefully matched control individuals with childhood malignancy but without a second cancer. By antibody microarrays, we screened primary fibroblasts of matched patients for differences in the amount of representative DNA repair-associated proteins. We found constitutively decreased levels of RAD9A and several other DNA repair proteins in two-cancer patients, compared to one-cancer patients. The RAD9A protein level increased in response to DNA damage, however to a lesser extent in the two-cancer patients. Quantification of mRNA expression by real-time RT PCR revealed lower RAD9A mRNA levels in both untreated and 1 Gy gamma-irradiated cells of two-cancer patients.
Conclusions/Significance:
Collectively, our results support the idea that modulation of RAD9A and other cell cycle arrest and DNA repair proteins contribute to the risk of developing a second malignancy in childhood cancer patients.
Background: The etiology of secondary cancer in childhood cancer survivors is largely unclear. Exposure of normal somatic cells to radiation and/or chemotherapy can damage DNA and if not all DNA lesions are properly fixed, the mis-repair may lead to pathological consequences. It is plausible to assume that genetic differences, i.e. in the pathways responsible for cell cycle control and DNA repair, play a critical role in the development of secondary cancer. Methodology/Findings: To identify factors that may influence the susceptibility for second cancer formation, we recruited 20 individuals who survived a childhood malignancy and then developed a second cancer as well as 20 carefully matched control individuals with childhood malignancy but without a second cancer. By antibody microarrays, we screened primary fibroblasts of matched patients for differences in the amount of representative DNA repair-associated proteins. We found constitutively decreased levels of RAD9A and several other DNA repair proteins in two-cancer patients, compared to onecancer patients. The RAD9A protein level increased in response to DNA damage, however to a lesser extent in the twocancer patients. Quantification of mRNA expression by real-time RT PCR revealed lower RAD9A mRNA levels in both untreated and 1 Gy c-irradiated cells of two-cancer patients. Conclusions/Significance: Collectively, our results support the idea that modulation of RAD9A and other cell cycle arrest and DNA repair proteins contribute to the risk of developing a second malignancy in childhood cancer patients.
DNA methylation is an epigenetic modification that plays an important role in gene regulation. It can be influenced by stochastic events, environmental factors and developmental programs. However, little is known about the natural variation of genespecific methylation patterns. In this study, we performed quantitative methylation analyses of six differentially methylated imprinted genes (H19, MEG3, LIT1, NESP55, PEG3 and SNRPN), one hypermethylated pluripotency gene (OCT4) and one hypomethylated tumor suppressor gene (APC) in chorionic villus, fetal and adult cortex, and adult blood samples. Both average methylation level and range of methylation variation depended on the gene locus, tissue type and/or developmental stage. We found considerable variability of functionally important methylation patterns among unrelated healthy individuals and a trend toward more similar methylation levels in monozygotic twins than in dizygotic twins. Imprinted genes showed relatively little methylation changes associated with aging in individuals who are >25 years. The relative differences in methylation among neighboring CpGs in the generally hypomethylated APC promoter may not only reflect stochastic fluctuations but also depend on the tissue type. Our results are consistent with the view that most methylation variation may arise after fertilization, leading to epigenetic mosaicism.